2021
Privacy-protecting, reliable response data discovery using COVID-19 patient observations
Kim J, Neumann L, Paul P, Day M, Aratow M, Bell D, Doctor J, Hinske L, Jiang X, Kim K, Matheny M, Meeker D, Pletcher M, Schilling L, SooHoo S, Xu H, Zheng K, Ohno-Machado L, Anderson D, Anderson N, Balacha C, Bath T, Baxter S, Becker-Pennrich A, Bernstam E, Carter W, Chau N, Choi Y, Covington S, DuVall S, El-Kareh R, Florian R, Follett R, Geisler B, Ghigi A, Gottlieb A, Hu Z, Ir D, Knight T, Koola J, Kuo T, Lee N, Mansmann U, Mou Z, Murphy R, Neumann L, Nguyen N, Niedermayer S, Park E, Perkins A, Post K, Rieder C, Scherer C, Soares A, Soysal E, Tep B, Toy B, Wang B, Wu Z, Zhou Y, Zucker R. Privacy-protecting, reliable response data discovery using COVID-19 patient observations. Journal Of The American Medical Informatics Association 2021, 28: 1765-1776. PMID: 34051088, PMCID: PMC8194878, DOI: 10.1093/jamia/ocab054.Peer-Reviewed Original Research
2019
Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
Wu Y, Warner J, Wang L, Jiang M, Xu J, Chen Q, Nian H, Dai Q, Du X, Yang P, Denny J, Liu H, Xu H. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing. JCO Clinical Cancer Informatics 2019, 3: cci.19.00001. PMID: 31141421, PMCID: PMC6693869, DOI: 10.1200/cci.19.00001.Peer-Reviewed Original ResearchConceptsVanderbilt University Medical CenterCancer survivalMayo ClinicDrug repurposingNoncancer drugsElectronic health record dataCancer registry dataEHR dataClinical trial evaluationOverall cancer survivalUniversity Medical CenterHealth record dataElectronic health recordsTreatment of cancerClinical trialsDrug classesRegistry dataMedical CenterDrug effectsSignificant associationLongitudinal EHRNew indicationsPatientsCancerHealth records
2015
Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer
Zhang Y, Franzini L, Chan W, Xu H, Du X. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal Of Health Care For The Poor And Underserved 2015, 26: 1336-1358. PMID: 26548682, DOI: 10.1353/hpu.2015.0119.Peer-Reviewed Original ResearchConceptsRisk of mortalityColorectal cancerTumor stagePrivate health insuranceCancer patientsHealth insuranceCancer-directed surgeryColorectal cancer patientsTexas Cancer RegistryInsurance coverageAdditional private health insuranceBreast cancer patientsHealth insurance statusHealth insurance coverageOverall survivalCancer RegistryInsurance statusBreast cancerLarge cohortHigh riskMedicare beneficiariesPatientsCancerChemotherapySurgery
2014
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
Xu H, Aldrich M, Chen Q, Liu H, Peterson N, Dai Q, Levy M, Shah A, Han X, Ruan X, Jiang M, Li Y, St Julien J, Warner J, Friedman C, Roden D, Denny J. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. Journal Of The American Medical Informatics Association 2014, 22: 179-191. PMID: 25053577, PMCID: PMC4433365, DOI: 10.1136/amiajnl-2014-002649.Peer-Reviewed Original ResearchConceptsType 2 diabetes patientsElectronic health recordsCancer patientsCancer mortalityDiabetes patientsEHR dataNon-diabetic cancer patientsCox proportional hazards modelDrug exposure informationOral hypoglycemic medicationsCharlson Comorbidity IndexNon-diabetic patientsUse of metforminCancer diagnosisHealth recordsSite-specific cancersBody mass indexProportional hazards modelVanderbilt University Medical CenterUniversity Medical CenterLarge electronic health recordHypoglycemic medicationsCause mortalityComorbidity indexInsulin use